Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

US Patent 11254681 · Granted Feb 22, 2022

Assignee

Inventors

View full patent text on Google Patents →